Individually tailored screening of susceptibility to sarcopenia using p53 codon 72 polymorphism, phenotypes, and conventional risk factors

Disease Markers

Volumn 2014, Issue , 2014, Pages

  Di Renzo, Laura ^a,b   Gratteri, Santo ^c   Sarlo, Francesca ^d   Cabibbo, Andrea ^a   Colica, Carmen ^c   De Lorenzo, Antonino ^a,b,e  

^a UNIVERSITY OF ROME TOR VERGATA   (Italy)

^b Nuova Clinica Annunziatella   (Italy)

^c UNIVERSITY MAGNA GRAECIA OF CATANZARO   (Italy)

^d UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^e National Institute for Mediterranean Diet and Nutrigenomics (INDiM)   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN P53; CODON;

ADULT; ALLELE; ANTHROPOMETRY; ARTICLE; ATTRIBUTABLE RISK; BODY COMPOSITION; BODY FAT; BODY MASS; CAUCASIAN; CLINICAL TRIAL; CODON; DNA POLYMORPHISM; DUAL ENERGY X RAY ABSORPTIOMETRY; FEMALE; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC PREDISPOSITION; GENETIC RISK; GENOTYPE; HETEROZYGOTE; HIP CIRCUMFERENCE; HUMAN; ITALIAN (CITIZEN); LEAN BODY WEIGHT; MAJOR CLINICAL STUDY; MUSCULOSKELETAL SYSTEM PARAMETERS; NUTRITIONAL STATUS; OBESITY; PHENOTYPE; RESTING METABOLIC RATE; SARCOPENIA; SKELETAL MUSCLE MASS; UNDERWEIGHT; WAIST CIRCUMFERENCE; WAIST HIP RATIO; ADOLESCENT; AGED; BIOLOGICAL MODEL; BODY WEIGHT; COMPLICATION; GENETICS; MIDDLE AGED; RISK FACTOR; SINGLE NUCLEOTIDE POLYMORPHISM;

ADOLESCENT; ADULT; AGED; BODY WEIGHT; CODON; FEMALE; HUMANS; MIDDLE AGED; MODELS, GENETIC; OBESITY; PHENOTYPE; POLYMORPHISM, SINGLE NUCLEOTIDE; RISK FACTORS; SARCOPENIA; TUMOR SUPPRESSOR PROTEIN P53;

EID: 84908374063     PISSN: 02780240     EISSN: 18758630     Source Type: Journal    
DOI: 10.1155/2014/743634     Document Type: Article

References (59)

1. Mensah G. A., Mokdad A. H., Ford E., Narayan K. M. V., Giles W. H., Vinicor F., Deedwania P. C., Obesity, metabolic syndrome, and type 2 diabetes: emerging epidemics and their cardiovascular implications. Cardiology Clinics 2004 22 4 485 504 10.1016/j.ccl.2004.06.005 2-s2.0-6344228286
2. Shuldiner A. R., Obesity genes and gene-environment-behavior interactions: recommendations for a way forward. Obesity 2008 16, supplement 3 S79 S81 10.1038/oby.2008.523 2-s2.0-56849097270
3. Tian Q., Price N. D., Hood L., Systems cancer medicine: towards realization of predictive, preventive, personalized and participatory (P4) medicine. Journal of Internal Medicine 2012 271 2 111 121 10.1111/j.1365-2796.2011.02498.x 2-s2.0-84855929701
4. Jenkins S. L., Maayan A., Systems pharmacology meets predictive, preventive, personalized and participatory medicine. Pharmacogenomics 2013 14 2 119 122 10.2217/pgs.12.186 2-s2.0-84872508370
5. Reiling E., Lyssenko V., Boer J. M. A., Codon 72 polymorphism (rs1042522) of TP53 is associated with changes in diastolic blood pressure over time. European Journal of Human Genetics 2012 20 6 696 700 10.1038/ejhg.2011.240 2-s2.0-84861190823
6. Leu J. I., Murphy M. E., George D. L., The p53 codon 72 polymorphism modifies the cellular response to inflammatory challenge in the liver. Journal of Liver 2013 2 1
7. Couture O., Lombardi E., Davis K., Hays E., Chandar N., Gene expression profiles resulting from stable loss of p53 mirrors its role in tissue differentiation. PLoS ONE 2013 8 11 e82494 10.1371/journal.pone.0082494 2-s2.0-84896729397
8. Lynch C. J., Shah Z. H., Allison S. J., Ahmed S. U., Ford J., Warnock L. J., Li H., Serrano M., Milner J., SIRT1 undergoes alternative splicing in a novel auto-regulatory loop with p53. PLoS ONE 2010 5 10 e13502 10.1371/journal.pone.0013502 2-s2.0-78149421022
9. Jeong B.-S., Hu W., Belyi V., Rabadan R., Levine A. J., Differential levels of transcription of p53-regulated genes by the arginine/proline polymorphism: P53 with arginine at codon 72 favors apoptosis. The FASEB Journal 2010 24 5 1347 1353 10.1096/fj.09-146001 2-s2.0-77952301694
10. Schwarzkopf M., Coletti D., Marazzi G., Sassoon D., p53 activity induces muscle atrophy and stem cell perturbation. Basic Applied Myology 2008 18 5 131 138
11. Porrello A., Cerone M. A., Coen S., Gurtner A., Fontemaggi G., Cimino L., Piaggio G., Sacchi A., Soddu S., p53 regulates myogenesis by triggering the differentiation activity of pRb. Journal of Cell Biology 2000 151 6 1295 1303 10.1083/jcb.151.6.1295 2-s2.0-0034638841
12. Teixeira V. D. O. N., Filippin L. I., Xavier R. M., Mechanisms of muscle wasting in sarcopenia. Revista Drasileira de Reumatologia 2012 52 2 252 259 10.1590/S0482-50042012000200009 2-s2.0-84864876012
13. Vogelstein B., Lane D., Levine A. J., Surfing the p53 network. Nature 2000 408 6810 307 310 10.1038/35042675 2-s2.0-0034676455
14. Evans W. J., Skeletal muscle loss: cachexia, sarcopenia, and inactivity. The American Journal of Clinical Nutrition 2010 91 4 1123S 1127S 10.3945/ajcn.2010.28608A 2-s2.0-77950485782
15. Cruz-Jentoft A. J., Baeyens J. P., Bauer J. M., Sarcopenia: European consensus on definition and diagnosis: report of the European Working Group on Sarcopenia in Older People. Age and Ageing 2010 39 4 412 423 10.1093/ageing/afq034 2-s2.0-77953870112
16. Fanzani A., Conraads V. M., Penna F., Martinet W., Molecular and cellular mechanisms of skeletal muscle atrophy: an update. Journal of Cachexia, Sarcopenia and Muscle 2012 3 3 163 179 10.1007/s13539-012-0074-6 2-s2.0-84865799919
17. Chung J.-Y., Kang H.-T., Lee D.-C., Lee H.-R., Lee Y.-J., Body composition and its association with cardiometabolic risk factors in the elderly: a focus on sarcopenic obesity. Archives of Gerontology and Geriatrics 2013 56 1 270 278 10.1016/j.archger.2012.09.007 2-s2.0-84869495015
18. Silva A. O., Karnikowski M. G. O., Funghetto S. S., Stival M. M., Lima R. M., de Souza J. C., Navalta J. W., Prestes J., Association of body composition with sarcopenic obesity in elderly women. International Journal of General Medicine 2013 6 25 29 10.2147/IJGM.S36279 2-s2.0-84874723667
19. Coin A., Sarti S., Ruggiero E., Giannini S., Pedrazzoni M., Minisola S., Rossini M., Del Puente A., Inelmen E. M., Manzato E., Sergi G., Prevalence of sarcopenia based on different diagnostic criteria using DEXA and appendicular skeletal muscle mass reference values in an italian population aged 20 to 80. Journal of the American Medical Directors Association 2013 14 7 507 512 10.1016/j.jamda.2013.02.010 2-s2.0-84879600987
20. de Lorenzo A., Martinoli R., Vaia F., di Renzo L., Normal weight obese (NWO) women: an evaluation of a candidate new syndrome. Nutrition, Metabolism and Cardiovascular Diseases 2006 16 8 513 523 10.1016/j.numecd.2005.10.010 2-s2.0-33749133898
21. de Lorenzo A., del Gobbo V., Premrov M. G., Bigioni M., Galvano F., di Renzo L., Normal-weight obese syndrome: early inflammation? The American Journal of Clinical Nutrition 2007 85 1 40 45 2-s2.0-33846087022
22. di Renzo L., del Gobbo V., Bigioni M., Premrov M. G., Cianci R., De Lorenzo A., Body composition analyses in normal weight obese women. European Review for Medical and Pharmacological Sciences 2006 10 4 191 196 2-s2.0-33748555194
23. World Health Organization, Obesity: Preventing and Managing the Global Epidemic.Report Series 894 on a WHO Consultation on Obesity 2000 Geneva, Swizerland World Health Organization
24. De Lorenzo A., Bianchi A., Maroni P., Iannarelli A., Di Daniele N., Iacopino L., Di Renzo L., Adiposity rather than BMI determines metabolic risk. International Journal of Cardiology 2013 166 1 111 117 10.1016/j.ijcard.2011.10.006 2-s2.0-84877774217
25. Wang J., Thornton J. C., Bari S., Williamson B., Gallagher D., Heymsfield S. B., Horlick M., Kotler D., Laferrère B., Mayer L., Xavier Pi-Sunyer F., Pierson R. N. Jr., Comparisons of waist circumferences measured at 4 sites. The American Journal of Clinical Nutrition 2003 77 2 379 384 2-s2.0-0037306080
26. De la Calle-Martin O., Fabregat V., Romero M., Soler J., Vives J., Yague J., AccII polymorphism of the p53 gene. Nucleic Acids Research 1990 18 16 4963 2-s2.0-0025127675
27. Bruzzi P., Green S. B., Byar D., Brinton L. A., Schairer C., Estimating the population attributable risk for multiple risk factors using case-control data. American Journal of Epidemiology 1985 122 5 904 914 2-s2.0-0022353142
28. Henley-Smith C. J., Steffens F. E., Botha F. S., Lall N., Predicting the influence of multiple components on microbial inhibition using a logistic response model-a novel approach. BMC Complementary and Alternative Medicine 2014 14 1, article 190
29. Hocking R. R., The analysis and selection of variables in linear regression. Biometrics 1976 32 1 1 49 MR0398008 2-s2.0-0017280570
30. Marcus R. L., Addison O., Dibble L. E., Foreman K. B., Morrell G., Lastayo P., Intramuscular adipose tissue, sarcopenia, and mobility function in older individuals. Journal of Aging Research 2012 2012 6 629637 10.1155/2012/629637 2-s2.0-84866628227
31. Conte M., Vasuri F., Trisolino G., Bellavista E., Santoro A., Degiovanni A., Martucci E., D'Errico-Grigioni A., Caporossi D., Capri M., Maier A. B., Seynnes O., Barberi L., Musarò A., Narici M. V., Franceschi C., Salvioli S., Increased Plin2 expression in human skeletal muscle is associated with sarcopenia and muscle weakness. PLoS ONE 2013 8 8 e73709 10.1371/journal.pone.0073709 2-s2.0-84881572578
32. Molkentin J. D., Olson E. N., Defining the regulatory networks for muscle development. Current Opinion in Genetics & Development 1996 6 4 445 453 10.1016/S0959-437X(96)80066-9 2-s2.0-0030219748
33. Parker S. B., Eichele G., Zhang P., Rawls A., Sands A. T., Bradley A., Olson E. N., Harper J. W., Elledge S. J., p53-independent expression of p21Cip1 in muscle and other terminally differentiating cells. Science 1995 267 5200 1024 1027 10.1126/science.7863329 2-s2.0-0028986639
34. Vousden K. H., Lane D. P., p53 in health and disease. Nature Reviews Molecular Cell Biology 2007 8 4 275 283 10.1038/nrm2147 2-s2.0-33947534030
35. Tyner S. D., Venkatachalam S., Choi J., Jones S., Ghebranious N., Igelmann H., Lu X., Soron G., Cooper B., Brayton C., Sang H. P., Thompson T., Karsenty G., Bradley A., Donehower L. A., p53 mutant mice that display early ageing-associated phenotypes. Nature 2002 415 6867 45 53 10.1038/415045a 2-s2.0-0037011958
36. Mazzaro G., Bossi G., Coen S., Sacchi A., Soddu S., The role of wild-type p53 in the differentiation of primary hemopoietic and muscle cells. Oncogene 1999 18 42 5831 5835 10.1038/sj.onc.1202962 2-s2.0-0033554598
37. Machida S., Booth F. W., Increased nuclear proteins in muscle satellite cells in aged animals as compared to young growing animals. Experimental Gerontology 2004 39 10 1521 1525 10.1016/j.exger.2004.08.009 2-s2.0-6944247865
38. Su M., Mei Y., Sinha S., Role of the crosstalk between autophagy and apoptosis in cancer. Journal of Oncology 2013 2013 14 102735 10.1155/2013/102735
39. Rommel C., Bodine S. C., Clarke B. A., Rossman R., Nunez L., Stitt T. N., Yancopoulos G. D., Glass D. J., Mediation of IGF-1-induced skeletal myotube hypertrophy by Pl(3)K/Alt/mTOR and Pl(3)K/Akt/GSK3 pathways. Nature Cell Biology 2001 3 11 1009 1013 10.1038/ncb1101-1009 2-s2.0-0035735902
40. Kandarian S. C., Jackman R. W., Intracellular signaling during skeletal muscle atrophy. Muscle and Nerve 2006 33 2 155 165 10.1002/mus.20442 2-s2.0-32144457727
41. Yaron A., Hatzubai A., Davis M., Identification of the receptor component of the I B α -ubiquitin ligase. Nature 1998 396 6711 590 594 10.1038/25159 2-s2.0-17944401842
42. Romero-Corral A., Somers V. K., Sierra-Johnson J., Korenfeld Y., Boarin S., Korinek J., Jensen M. D., Parati G., Lopez-Jimenez F., Normal weight obesity: a risk factor for cardiometabolic dysregulation and cardiovascular mortality. European Heart Journal 2010 31 6 737 746 10.1093/eurheartj/ehp487 2-s2.0-77951960109
43. Marques-Vidal P., Pécoud A., Hayoz D., Paccaud F., Mooser V., Waeber G., Vollenweider P., Prevalence of normal weight obesity in Switzerland: effect of various definitions. European Journal of Nutrition 2008 47 5 251 257 10.1007/s00394-008-0719-6 2-s2.0-48749089948
44. di Renzo L., Bigioni M., Bottini F. G., Normal Weight Obese syndrome: role of single nucleotide polymorphism of IL-15R-alpha and MTHFR 677CT genes in the relationship between body composition and resting metabolic rate. European Review for Medical and Pharmacological Sciences 2006 10 5 235 245
45. Di Renzo L., Bigioni M., del Gobbo V., Interleukin-1 (IL-1) receptor antagonist gene polymorphism in normal weight obese syndrome: relationship to body composition and IL-1 α and β plasma levels. Pharmacological Research 2007 55 2 131 138 10.1016/j.phrs.2006.11.002 2-s2.0-33846574357
46. di Renzo L., Bertoli A., Bigioni M., del Gobbo V., Premrov M. G., Calabrese V., di Daniele N., de Lorenzo A., Body composition and -174G/C interleukin-6 promoter gene polymorphism: association with progression of insulin resistance in normal weight obese syndrome. Current Pharmaceutical Design 2008 14 26 2699 2706 10.2174/138161208786264061 2-s2.0-57349134914
47. Di Renzo L., Galvano F., Orlandi C., Bianchi A., Di Giacomo C., La Fauci L., Acquaviva R., De Lorenzo A., Oxidative stress in normal-weight obese syndrome. Obesity 2010 18 11 2125 2130
48. Kang S., Kyung C., Park J. S., Kim S., Lee S.-P., Kim M. K., Kim H. K., Kim K. R., Jeon T. J., Ahn C. W., Subclinical vascular inflammation in subjects with normal weight obesity and its association with body Fat: an 18 F-FDG-PET/CT study. Cardiovascular Diabetology 2014 13 1, article 70 10.1186/1475-2840-13-70 2-s2.0-84899487096
49. Madeira F. B., Silva A. A., Veloso H. F., Goldani M. Z., Kac G., Cardoso V. C., Bettiol H., Barbieri M. A., Normal weight obesity is associated with metabolic syndrome and insulin resistance in young adults from a middle-income country. PLoS ONE 2013 8 3 e60673 10.1371/journal.pone.0060673 2-s2.0-84875544818
50. Oliveros E., Somers V. K., Sochor O., Goel K., Lopez-Jimenez F., The concept of normal weight obesity. Progress in Cardiovascular Diseases 2014 56 4 426 433 10.1016/j.pcad.2013.10.003 2-s2.0-84892446007
51. Kim J., Wang Z., Heymsfield S. B., Baumgartner R. N., Gallagher D., Total-body skeletal muscle mass: estimation by a new dual-energy X-ray absorptiometry method. The American Journal of Clinical Nutrition 2002 76 2 378 383 2-s2.0-0036075719
52. Janssen I., Katzmarzyk P. T., Ross R., Waist circumference and not body mass index explains obesity-related health risk. The American Journal of Clinical Nutrition 2004 79 3 379 384 2-s2.0-1642415851
53. Tchoukalova Y. D., Votruba S. B., Tchkonia T., Giorgadze N., Kirkland J. L., Jensen M. D., Regional differences in cellular mechanisms of adipose tissue gain with overfeeding. Proceedings of the National Academy of Sciences of the United States of America 2010 107 42 18226 18231 10.1073/pnas.1005259107 2-s2.0-78149236460
54. Tchoukalova Y. D., Koutsari C., Karpyak M. V., Votruba S. B., Wendland E., Jensen M. D., Subcutaneous adipocyte size and body fat distribution. The American Journal of Clinical Nutrition 2008 87 1 56 63 2-s2.0-38149006999
55. Roubenoff R., Catabolism of aging: is it an inflammatory process? Current Opinion in Clinical Nutrition and Metabolic Care 2003 6 3 295 299 10.1097/00075197-200305000-00005 2-s2.0-0037927688
56. Shapira N., Women's higher health risks in the obesogenic environment: a gender nutrition approach to metabolic dimorphism with predictive, preventive, and personalised medicine. The EPMA Journal 2013 4 1 1 10.1186/1878-5085-4-1
57. De Lorenzo A., Nardi A., Iacopino L., Domino E., Murdolo G., Gavrila C., Minella D., Scapagnini G., Di Renzo L., A for evaluating women body fat percentage and obesity-related cardiovascular disease risk. Journal of Endocrinological Investigation 2014 37 6 511 524 10.1007/s40618-013-0048-3
58. Hood L., Heath J. R., Phelps M. E., Lin B., Systems biology and new technologies enable predictive and preventative medicine. Science 2004 306 5696 640 643 10.1126/science.1104635 2-s2.0-7444253428
59. Carter G. W., Galas D. J., Galitski T., Maximal extraction of biological information from genetic interaction data. PLoS Computational Biology 2009 5 4 e1000347 10.1371/journal.pcbi.1000347 2-s2.0-65349180167